| 000 | 00978agm a2200289u 4500 | ||
|---|---|---|---|
| 001 | 996099110102311 | ||
| 005 | 20260227104100.0 | ||
| 007 | mr caaud | ||
| 008 | 790516u1975 mdu038uf 0mueng d | ||
| 035 | _a(TU)000609911UTK01 | ||
| 035 | 9 | _a641691 | |
| 035 | _a(OCoLC)04969187 | ||
| 040 |
_aOCM _cOCM _dMNM _dOCL _dTKN |
||
| 049 | _aTKNk | ||
| 090 |
_aRC385 _b.D7x |
||
| 090 |
_aRC394.T37 _bD7 |
||
| 099 | _aRC394.T37D7 | ||
| 245 | 0 | 0 |
_aDrug induced extrapyramidal reactions. _h[motion picture]. |
| 260 |
_aBaltimore, MD : _bAyd Medical Communications, _c[1975?] |
||
| 300 |
_a1 film, 38 min. : _bsd.,col. ; _c16mm. |
||
| 520 | _aDeals with patients with neuroleptic-induced extrapyramidal reactions. Compares patients with tardive dyskinesia to those with L-dopa induced dyskinesia. | ||
| 650 | 0 | _aTardive dyskinesia. | |
| 650 | 0 | _aMovement disorders. | |
| 650 | 0 | _aExtrapyramidal tracts. | |
| 710 | 2 | _aAyd Medical Communications. | |
| 966 | _aprimo | ||
| 999 |
_c222 _d222 |
||